CG Policy · 2025
In this section7 topics
Corporate Governance Policy
Has a Corporate Governance Policy
Yes
Policy Description
The Company realizes the importance of good corporate governance, which is an important issue that promotes the Company's operations to be efficient and grow sustainably. That will lead to the utmost benefit to all stakeholders, from employees, investors, shareholders and other stakeholders. Therefore, the Board of Directors agrees that a better corporate governance policy should be established covering key principles from structure, roles, duties and responsibilities of the Board of Directors to the management principles of the executives providing transparent, transparent and verifiable to be a guideline for managing the organization and to make the belief that any operation of the Company is appropriate to the best interests of shareholders and all stakeholders. The Board of Directors places importance on compliance with good corporate governance principles; therefore, it has established a policy of Good Corporate Governance Policy in writing, which is prepared in accordance with the principles of the Corporate Governance Code for listed companies 2017 of the Office of the Securities and Exchange Commission as a guideline. The policy comprises 8 practices, as follows;
Principle 1: Establish a clear leadership role and responsibilities of the board
Principle 2: Define objectives that promote sustainable value creation
Principle 3: Strengthen board effectiveness
Principle 4: Ensure effective CEO and people management
Principle 5: Nurture innovation and responsible business
Principle 6: Strengthen effective risk management and internal control
Principle 7: Ensure disclosure and financial integrity
Principle 8: Ensure engagement and communication with shareholders
Policy Document Link
https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-cg-policy-en.pdf
Policy & Practices — Board of Directors
Has Policy & Guidelines for the Board
Yes
Board Guidelines
| Guideline | Detail |
|---|---|
| Nomination of Directors | The Company places importance on a systematic and transparent process for the nomination and selection of directors in accordance with the principles of good corporate governance. The objective is to ensure that the Board of Directors comprises individuals with the appropriate knowledge, capabilities, experience, and qualifications to effectively oversee and guide the Company’s business operations. The Company has assigned the Nomination and Remuneration Committee to consider, screen, and nominate qualified individuals for directorship. In this process, the Committee takes into consideration the candidates’ qualifications, knowledge, expertise, experience, and skills that would be beneficial to the Company’s business operations. The overall structure of the Board is also considered in order to ensure an appropriate balance of skills and experience (Board Skill Matrix) aligned with the Company’s strategy and business direction. In nominating directors, the Company also takes into account Board Diversity in terms of knowledge, expertise, business experience, gender, age, and independence of directors, in order to enhance the effectiveness of corporate governance and strategic decision-making. Individuals nominated for directorship must possess the required qualifications and must not have any prohibited characteristics as prescribed by applicable laws, including the regulations of the Securities and Exchange Commission and the Stock Exchange of Thailand. The nominated candidates will be proposed to the Board of Directors for consideration before being submitted to the shareholders’ meeting for approval of the appointment in accordance with the prescribed procedures. |
| Determination of Director Remuneration | The Company has the policy to set the remuneration for directors to be in accordance with the Company's strategy and long-term goals by considering experience, duties, the scope of roles and responsibilities (accountability and responsibility), including expected benefits for directors who are assigned more duties and responsibilities. For example, being a member of a sub-committee will receive appropriate additional remuneration. The rate of remuneration of directors is comparable to other businesses in the same industry which the Board of Directors has assigned the Nomination and Remuneration Committee to consider the structure and rate of directors' remuneration, both monetary and non-monetary, to be appropriate both remuneration at a fixed rate (such as regular compensation meeting allowance) and remuneration according to the Company's performance (such as bonuses, gratuities) and propose to the Board of Directors meeting for consideration and present to the Shareholders’ Meeting for approval annually. |
| Independence of the Board of Directors from the Management | The Company places great importance on good corporate governance and aims to ensure that the Board of Directors can perform its oversight and advisory roles independently, transparently, and effectively. This is to maintain an appropriate balance between the roles of the Board of Directors and the management team. The Company has established a Board structure with an appropriate proportion of independent directors in accordance with the regulations of the Securities and Exchange Commission and the Stock Exchange of Thailand. Independent directors play an important role in providing checks and balances and overseeing the management’s operations. Independent directors are required to possess the qualifications and independence as prescribed by relevant laws and regulations, and must be able to express their opinions and provide recommendations on the Company’s business operations independently. In addition, the Company clearly separates the roles and responsibilities between the Board of Directors and the management team. The Board of Directors is responsible for setting policies, vision, strategies, and overseeing the Company’s operations, while the management team is responsible for managing and operating the business in accordance with the policies and strategies established by the Board. To further strengthen independent oversight, the Company has established subcommittees, such as the Audit Committee and the Nomination and Remuneration Committee, which mainly consist of independent directors. These committees are responsible for reviewing and providing opinions on important matters before submitting them to the Board of Directors for consideration. Furthermore, the Company supports the Board of Directors in having adequate and timely access to information necessary for the performance of their duties. The Board may also seek advice from external experts when appropriate to ensure that decisions are made prudently, transparently, and in the best interests of the Company and its shareholders as a whole. |
| Director Development | The Board of Directors supports and promotes knowledge development for the Board of Directors to attend various training courses which beneficial to the performance of the Board of Directors provide up-to-date knowledge, innovation, the new management style of business that is always competitive and able to apply knowledge appropriately. All directors of the Company attended the training course for directors from the Thai Institute of Directors (IOD) and regularly attend additional training courses, details are in the attached 1. |
| Board Performance Evaluation | The Company recognizes the importance of Board performance evaluation as an essential mechanism for enhancing the effectiveness of corporate governance. The evaluation process supports the Board of Directors in performing its duties with efficiency, transparency, and accountability, in alignment with the principles of good corporate governance. The Company conducts an annual performance evaluation of the Board of Directors, covering multiple levels of assessment, including the evaluation of the Board as a whole, individual director self-assessment, sub-committee performance evaluation, and the performance evaluation of the Chief Executive Officer. The evaluation results serve as a key input for improving the Board’s effectiveness in providing strategic direction, overseeing management performance, and supporting the management in achieving the Company’s objectives. The evaluation forms are developed in accordance with the guidelines recommended by the Stock Exchange of Thailand and consist of four types as follows:
The evaluation results are expressed as a percentage of the total score and categorized into the following levels:
|
| Corporate Governance of Subsidiaries and Associated Companies | 1. The Company has the policy to invest in businesses that are related to the core business of the Company and that have the potential to generate profits and have growth opportunities to increase the Company's profitability or be beneficial businesses (synergy) to the Company by realizing the return that will be received from the investment through controlling and supervising the management of the subsidiary as if it were a unit of the Company. Also, it shall monitor the management to maintain the benefits of the Company's investments continuously and sustainably, create added value, and build confidence among the Company's stakeholders. Therefore, the Company has established a policy to control and supervise subsidiaries and associated companies that it has invested in with the following details. The Company has established the management structure of its subsidiaries and associated companies to oversee the management and be responsible for the operations of the subsidiaries and associated companies as follows: Nomination of Individuals to be Directors and Executives of the Subsidiaries and Associated Companies 1.1 The Company will send individuals approved by the Board of Directors Meeting to be directors and executives in the subsidiaries and associated companies to supervise and establish the management policy as a part of the Company. The number of people who will join as directors in the subsidiaries are mainly based on the Company's shareholding in the subsidiaries or in accordance with an agreement. For investments in the associated companies, the Company needs the policy to control more. Submission of representatives to join as directors of the associated companies will be appropriately considered, depending on the agreement. Such individuals must have appropriate qualifications and experience in managing the business of such subsidiaries and associated companies. 1.2 Scope of Duties and Responsibilities of Directors and Executives in Subsidiaries and Associated Companies
2. Directors and executives of the subsidiaries, including the related individuals of such directors and executives, are responsible for reporting to the Board of Directors of the subsidiaries about the relationship and transactions with subsidiaries in ways that may cause conflicts of interest and shall avoid entering into any transactions that may cause conflicts of interest with such subsidiaries. In this regard, the Board of Directors of the subsidiaries is responsible for reporting such matters to the Company. Directors and executives of the subsidiaries must not participate in approving matters in which they have interests or conflicts of interest. 3. Subsidiaries are required to report business plans, investment projects, and joint ventures with other operators to the Company through the subsidiaries' monthly performance report including providing information or documents related to operations upon request. In the event that the Company detects any significant issues, it may notify the subsidiary to clarify and/or submit documents for consideration by the Company. 4. The Company has assigned financial control policies for subsidiaries and associated companies. The subsidiaries and associated companies have the duties as follows:
|
Code of Conduct
Has a Business Code of Conduct
Yes
Code of Conduct Description
The Board of Directors has encouraged the preparation of a Business Code of Conduct for directors, executives, and employees to adhere to and perform with common responsibilities, including promoting the practice and monitoring such practice for the utmost benefit of the Company's stakeholders as well as creating credibility in business operations that will lead the Company to grow sustainably. The Board of Directors regularly reviews the Code of Business Ethics on an annual basis.
Code of Conduct Link
https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf
Page Number in Report
1-17
Code of Conduct Practices
| Guideline | Detail | Document Link | Page Number in Report |
|---|---|---|---|
| Prevention of Misuse of Inside Information | 1. Directors, executives, and employees of the Company and its subsidiaries shall perform duties for the best interest of the Company, avoid any action in a manner that may cause a conflict of interest whether from contacting with people involved in the business such as business partners, customers, competitors, r from using opportunities or information obtained from being a director, executive or employee for personal benefits, and avoid doing business that competes with the Company or work other than the work of the Company which affects work on duties, including not using customer information for personal benefits. 2. Executives and employees of the Company and its subsidiaries shall refrain from holding shares in competitors which make the employees act or omit actions that should be performed according to duties or have an impact on the work in the duties. In the case that the employees have acquired such shares before being an employee or before the Company enters into that business. Acquire through inheritance, employees shall report to their superiors in hierarchical order. | https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf | 6 |
| Anti-corruption | Directors, executives, and employees of the Company and its subsidiaries are committed to opposing corruption both directly and indirectly, such as giving or accepting bribes or any incentives or entrusting others to give or accept bribes or incentives on behalf of themselves. Then, it requires all directors, executives, and employees to oppose corruption, including giving or accepting bribes strictly. In this regard, the Company has prepared a written anti-corruption policy as a guideline for operating business and developing the organization towards sustainability. The Company requires that its anti-corruption policy, as well as guidelines and operational requirements, be regularly reviewed to ensure alignment with changes in business, rules, regulations, and applicable laws. The Board of Directors reviews the anti-corruption policy on an annual basis, and in 2025, no complaints related to fraud or corruption were identified. | https://investor.interpharma.co.th/storage/downloads/corporate-governance/20220328-ip-cg-anti-corruption-th.pdf | 1-8 |
| Whistleblowing and Protection of Whistleblowers | The Company has a policy to receive complaints and give opportunities to those suspected or affected by illegal acts, unethical conduct, acts that imply corruption, or behavior that may cause damage to the Company. There are channels for making complaints or reporting clues to the Company. The whistleblowers are those who have seen, known clues, or suspected in good faith whether or not they will be damaged or affected by the Company's business operations or from the performance of duties by directors, executives, and employees who violate or fail to comply with the laws and regulations of the state or with good corporate governance principles, business ethics, policies, and regulations of the Company, including actions that may imply corruption. Those who see violations can report such sightings to the Board of Directors through the channels specified by the Company. In this regard, the reported matter will be considered for further investigation. The Company protects the reporters in the best possible way. However, In 2025, no whistleblowing or complaints were found related to non-compliance with business ethics, corruption, or human rights violations. Measures to Protect Whistleblowers or Complainants
Channels for Whistleblowing or Complaints About Misconduct or Any Complaints
Chairman of the Board and/or Chairman of the Audit Committee Inter Pharma Public Company Limited No. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong Sub-District, Bangrak District, Bangkok 10500 2. Electronic mail or e-mail at comsec@interpharma.co.th 3. Company website www.interpharma.co.th Investigation Process and Punishment The Company provides the opportunity for employees to have complaint channels and freely express their opinions as a guideline for development and sustainability for the organization as follows: 1. Upon receiving a whistleblower complaint, the Audit Committee will assign an internal auditor or appoint an investigation committee to screen and investigate the facts and periodically report the results of the investigation to the whistleblower or complainant. 2. Suppose the fact-finding investigation finds information or evidence that is reasonable to believe that the accused has committed an offense. In that case, the Company will give the accused the right to know the allegation and prove themself by obtaining additional information or evidence showing that they are not involved in the alleged offense. 3. If the accused has committed an offense, the offender, whether a director, executive, or employee, is considered an offender and will be subject to disciplinary action according to the regulations set by the Company. In addition, if the offense is against the law, the offender may be subject to legal penalties. According to the Company's regulations and the Audit Committee's decision, the disciplinary action is final. 4. As for reporting results, the Chairman of the Audit Committee, an independent director, or the Company Secretary shall report to the Board of Directors for acknowledgment and report to the stakeholders if the complainant reveals themself. | ||
| Preventing the Misuse of Inside Information | The Company and its subsidiaries recognize the importance of safeguarding the Company’s confidential and inside information. The Company has established a policy prohibiting directors, executives, and employees from disclosing or using any information that may affect the Company’s share price or any information that, if disclosed, could cause damage or disadvantage to the Company. Such information is considered confidential and material, including any undisclosed inside information. Directors, executives, and employees are strictly prohibited from using such information for personal benefit or for the benefit of others, whether directly or indirectly, and regardless of whether any consideration is received. In addition, they are prohibited from trading the Company’s securities based on inside information. To comply with the Securities and Exchange Act B.E. 1992 (as amended) and the regulations of the Stock Exchange of Thailand regarding information disclosure of listed companies, the Company has established guidelines to prevent the misuse of inside information. | ||
| Giving or receiving gifts, entertainment, or business entertainment | Directors, executives, and employees of the Company shall not solicit, accept, or agree to accept money, goods, or any other benefits from individuals who are business associates of the Company. However, directors, executives, and/or employees may customarily give or receive gifts, provided that the acceptance of such gifts does not affect any business decisions of the recipient, and the gifts received are of low value and should not be in the form of cash or cash equivalents. The Company has therefore established a policy and guidelines on the giving and receiving of gifts, hospitality, or any other benefits. | ||
| Compliance with laws, rules and regulations | All directors, executives, and employees of the company must strictly adhere to all company rules, policies, and regulations. Furthermore, in the operation of the Company, all directors, executives, and employees must strictly comply with all applicable laws, rules, and regulations governing the Company's operations. All directors, executives, and employees must have a thorough understanding of and be aware of all applicable laws, rules, and regulations governing the Company's operations, and regularly monitor any changes or amendments to these laws, rules, and regulations. | ||
| Use and maintenance of data and assets | All employees have the duty and responsibility to safeguard company assets, preventing damage or loss, and using them efficiently to maximize benefits for the company. They must not use company assets for their own benefit or the benefit of others. Furthermore, all employees must strictly avoid disclosing or misusing confidential information. Such assets include both tangible and intangible assets, such as movable property, immovable property, technology, academic knowledge, patents, copyrights, and confidential information not disclosed to the public, including business plans, financial forecasts, human resource data, etc. | ||
| Cyber security | 1. Directors, executives, and employees of the company must maintain the confidentiality of company information and news that has not been publicly disclosed, and must not use such information for any improper gain. Furthermore, all directors, executives, and employees must strictly avoid disclosing or using confidential company information. 2. All directors, executives, and employees must maintain company confidentiality by taking care to prevent the leakage of confidential company documents or information to others, which could cause damage to the company. This includes not disclosing confidential company documents or information to external parties unless authorized by a supervisor. 3. The Company must safeguard and protect personal information received and exercise the utmost care in handling such information to maintain the privacy of the data subject. The Company will use personal information only for business purposes as disclosed to the data subject at the time of data collection. | ||
| Environmental management | The Company recognizes the importance of environmental protection and has implemented measures to safeguard the environment and conserve natural resources. These measures include: using resources wisely; reducing raw material consumption; minimizing energy use (for production, transportation, and offices); controlling water consumption; utilizing renewable resources; caring for and restoring biodiversity affected by business operations; managing and discharging waste generated from business operations; mitigating greenhouse gas emissions; and promoting the development of environmentally friendly products. Furthermore, the Company encourages the participation of all employees and stakeholders in environmental conservation. | ||
| Occupational health and safety | The Company promotes and prioritizes safety for its employees and stakeholders to prevent accidents, injuries, and work-related illnesses. It strives to eliminate or control unsafe conditions associated with its business operations by establishing the following Safety, Occupational Health, and Working Environment Policy: 1. The Company considers workplace safety a responsibility of all employees, who must cooperate to ensure their own safety, the safety of others, and the safety of company property at all times during work. 2. The Company will promote and support improvements to the working environment and work methods to ensure safety and good hygiene, thereby promoting the safety and health of employees. 3. The Company will promote and support various safety activities that raise employee awareness. 4. Supervisors at all levels must act as role models, lead, train, instruct, and oversee employees to ensure they perform their work safely and strictly adhere to safety regulations. 5. All employees must cooperate with the Company's safety and occupational health programs and have the right to offer suggestions for improving working conditions and safer working methods. 6. The Company will strictly comply with all relevant laws and regulations. |
Promoting Compliance with the Code of Conduct
Promotes Compliance by Directors, Executives and Employees
Yes
Description
Compliance with Code of Business Conduct
The Company prescribes that it is the duties and responsibilities of the Board of Directors, executives, and all employees of the Company and its subsidiaries to acknowledge, understand, and strictly comply with the policies and procedures set forth in the "Code of Business Conduct." This is not voluntary, so they cannot claim that they are not aware of these established guidelines.
The Company has established guidelines for strengthening and supporting compliance with the Code of Business Conduct as follows:
The written Code of Business Conduct is prepared and disseminated widely for executives and employees at all levels to read, understand, and sign for acknowledgment of this Code of Business Conduct as well as adhere to as the operational guideline.
Executives at all levels in the Company shall take responsibility and place importance on ensuring that employees under their line management acknowledge, understand, and seriously comply with this Code of Business Conduct.
Values are cultivated, and organizational culture is created to promote ethical values, including:
Directors and top executives of the Company shall be good role models in morality and ethics.
To understand the importance of morals and ethics shall be strengthened through activities in various forms.
Guidelines for actions are set for any Code of Business Conduct problems, such as receiving complaints, investigation, protection of whistleblowers, and penalties.
5. The Code of Business Conduct is reviewed at least 1 time a year in order to ensure its suitability for the situation and changing business environment.
Receipt of Complaints about Code of Business Conduct
The Company has required all directors, executives, and employees to jointly monitor compliance with the Company's Code of Business Conduct. The Company has provided channels for complaints of violations or omissions to comply with the Company's Code of Business Conduct.
The Company shall keep the information received through the complaint channels confidential and treat it as confidential information. The complaint shall be protected from harassment during and after the investigation.
The Company shall deal with all complaints equally, transparently, and attentively, as well as being fair to all parties. The investigative period has been set appropriately and fairly.
Directors, executives, and employees witnessing any acts that violate or omit to comply with the Company's Code of Business Conduct can make complaints to the Company's complaint channels.
Process Document Link
https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf
Page Number in Report
13-14
Anti-Corruption Networks & Projects
Joined or Declared Intent to Join Anti-Corruption Networks
No
Networks & Projects Joined
| Network / Project |
|---|
| Thai Private Sector Collective Action Against Corruption: CAC |
| United Nations Global Compact (UNGC) |
| Participation of anti-Corruption networks and initiatives |
Material Changes & Developments in CG
Reviewed the CG Policy or Board Charter in the Past Year
Yes
Material Changes or Developments in the Past Year
Yes
Policy Review — Description
The Board of Directors regularly reviews the charters of the Board of Directors and its sub-committees, as well as key policies related to good corporate governance, on an annual basis.
In 2025, the Company formulated additional key policies and submitted them to the Board of Directors for consideration and approval, namely the Risk Management Policy, the Environmental Policy, and the Corporate Social Responsibility Policy, to ensure that the Company conducts its business in accordance with good corporate governance practices and sustainable business development, as well as in compliance with applicable rules, regulations, and relevant laws.
Implements the CG Code for Listed Companies
No
CG Code — Description
The Company gives importance to good corporate governance; therefore, relevant policies and guidelines have been specified in the Company's Corporate Governance Policy and Business Code of Conduct, as well as promoting actual practice to build confidence among all groups of stakeholders. During the past year, the Company monitored and ensured compliance with good corporate governance practices covering the following matters:
1) Employee care and non-discrimination
2) Anti-unfair competition
3) Caring for the environment, health, and safety in the organization
4) Information security
5) Human Rights
6) Anti-Corruption.
The monitoring results indicate that the Company has fully implemented the guidelines for each respective issue.
Other CG Performance & Outcomes
1. The Company received a full score of 100 points in the AGM Checklist assessment under the Annual General Meeting Quality Assessment Program for 2025, organized by the Thai Investors Association.
2. The Company received the results of the Corporate Governance Survey under the Corporate Governance Survey of Listed Companies for the year 2025, organized by the Thai Institute of Directors (IOD) with the support of the Stock Exchange of Thailand and the Securities and Exchange Commission (SEC). The Company was rated “Excellent” (5 stars) for its compliance with the principles of corporate governance for listed companies.
3. The Company applied to participate in the Listed Company Value Enhancement Program (JUMP+), organized by the Stock Exchange of Thailand, on 20 August 2025, to foster sustainable growth and enhance long-term value for the Company.

